Scarica l'app Stockscreener
16.45
0.86%
0.14
Dopo l'orario di chiusura:
16.31
-0.14
-0.85%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GLUE Giù?
Forum
Previsione
Precedente Chiudi:
$16.31
Aprire:
$16.34
Volume 24 ore:
656.42K
Relative Volume:
0.43
Capitalizzazione di mercato:
$1.07B
Reddito:
-
Utile/perdita netta:
$-130.41M
Rapporto P/E:
-7.3438
EPS:
-2.24
Flusso di cassa netto:
$-67.76M
1 W Prestazione:
-7.84%
1M Prestazione:
+14.55%
6M Prestazione:
+235.03%
1 anno Prestazione:
+117.59%
Intervallo 1D:
$16.17
$17.17
Intervallo di 1 settimana:
$16.17
$18.05
Portata 52W:
$3.5001
$18.15
Monte Rosa Therapeutics Inc Stock (GLUE) Company Profile
Nome
Monte Rosa Therapeutics Inc
Settore
Industria
Telefono
617-949-2643
Indirizzo
321 HARRISON AVENUE, BOSTON
Confronta GLUE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GLUE
Monte Rosa Therapeutics Inc
|
16.45 | 1.06B | 0 | -130.41M | -67.76M | -2.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Monte Rosa Therapeutics Inc Stock (GLUE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-19 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-02-15 | Iniziato | Wedbush | Outperform |
| 2023-01-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-10-13 | Iniziato | UBS | Buy |
| 2022-08-15 | Iniziato | Jefferies | Buy |
| 2022-04-28 | Iniziato | Credit Suisse | Neutral |
| 2022-02-10 | Iniziato | Wells Fargo | Equal Weight |
| 2021-10-14 | Iniziato | SVB Leerink | Mkt Perform |
Mostra tutto
Monte Rosa Therapeutics Inc Borsa (GLUE) Ultime notizie
Monte Rosa Therapeutics to Present Updated MRT-2359 Phase 1/2 Study Results - The Manila Times
Monte Rosa Therapeutics to Host Conference Call on Interim Results of MRT-2359 for mCRPC Treatment - Quiver Quantitative
Franklin Resources Inc. Raises Stock Holdings in Monte Rosa Therapeutics, Inc. $GLUE - Defense World
Monte Rosa Therapeutics (NASDAQ:GLUE) Sets New 52-Week HighStill a Buy? - MarketBeat
Monte Rosa Therapeutics (NASDAQ:GLUE) Nasdaq Futures Biotech Momentum - Kalkine Media
Monte Rosa Therapeutics (GLUE) Tops Q1 Earnings and Revenue Estimates - sharewise.com
Critical Survey: Monte Rosa Therapeutics (NASDAQ:GLUE) & Cogent Biosciences (NASDAQ:COGT) - Defense World
Monte Rosa Therapeutics stock hits 52-week high at $16.66 By Investing.com - Investing.com India
Monte Rosa Therapeutics stock hits 52-week high at $16.66 - Investing.com
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock Catapults 28% Though Its Price And Business Still Lag The Industry - simplywall.st
Monte Rosa Therapeutics (GLUE) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Improved Revenues Required Before Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock's 26% Jump Looks Justified - 富途牛牛
Monte Rosa: Looking Mispriced After Big Pharma Validation (NASDAQ:GLUE) - Seeking Alpha
How Monte Rosa Therapeutics Inc. stock reacts to inflationary pressuresQuarterly Earnings Summary & Real-Time Buy Signal Notifications - moha.gov.vn
Monte Rosa Therapeutics Jumps 124.9% in 2025 But Are Investors Getting Ahead of Themselves - Yahoo Finance
Hillsdale Investment Management Inc. Makes New $271,000 Investment in Monte Rosa Therapeutics, Inc. $GLUE - MarketBeat
Monte Rosa Therapeutics (NASDAQ:GLUE) Hits New 12-Month HighShould You Buy? - MarketBeat
Monte Rosa Therapeutics, Inc. (GLUE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Head-To-Head Review: Twist Bioscience (NASDAQ:TWST) versus Monte Rosa Therapeutics (NASDAQ:GLUE) - Defense World
Monte Rosa Therapeutics Inc. (GLUE) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Price momentum metrics for Monte Rosa Therapeutics Inc. explainedChart Signals & Proven Capital Preservation Tips - newser.com
Los Angeles Capital Management LLC Makes New Investment in Monte Rosa Therapeutics, Inc. $GLUE - MarketBeat
Monte Rosa Therapeutics finds novel molecular glue degrader - Traders Union
What to do if you’re stuck in Monte Rosa Therapeutics Inc.July 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
Integrated Quantitative Investments LLC Acquires New Holdings in Monte Rosa Therapeutics, Inc. $GLUE - MarketBeat
Monte Rosa Therapeutics Reports Strong Revenue Growth - MSN
22,500 Shares in Monte Rosa Therapeutics, Inc. $GLUE Acquired by Bailard Inc. - MarketBeat
What analysts say about Monte Rosa Therapeutics Inc stockFibonacci Retracement Levels & Free Explosive Earning Power - earlytimes.in
Is Monte Rosa Therapeutics Inc. meeting your algorithmic filter criteriaEarnings Miss & Verified Trade Idea Suggestions - newser.com
Is it time to cut losses on Monte Rosa Therapeutics Inc.Quarterly Investment Review & Entry and Exit Point Strategies - newser.com
Why Monte Rosa Therapeutics Inc. stock could benefit from AI revolutionMarket Volume Summary & Technical Pattern Alert System - newser.com
Custom watchlist performance reports with Monte Rosa Therapeutics Inc.Quarterly Growth Report & Community Driven Trade Alerts - newser.com
Why Monte Rosa Therapeutics Inc. stock is popular among millennialsJuly 2025 Highlights & Fast Moving Market Watchlists - newser.com
Published on: 2025-11-14 03:37:36 - newser.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Applied Therapeutics (APLT) and Xilio Therapeutics (XLO) - The Globe and Mail
Chart based exit strategy for Monte Rosa Therapeutics Inc.July 2025 Reactions & Safe Capital Growth Tips - newser.com
Trade Monte Rosa Therapeutics IncGLUE CFD - Capital.com
Monte Rosa Therapeutics (NASDAQ:GLUE) Shares Gap DownHere's Why - MarketBeat
GLUE Stock Price and Chart — NASDAQ:GLUE - TradingView
Forecasting Monte Rosa Therapeutics Inc. price range with options dataJuly 2025 Decliners & Long-Term Growth Plans - newser.com
Monte Rosa Therapeutics Inc Azioni (GLUE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):